Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
2
×
boston top stories
deals
gene therapy
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
startups
2
×
abbvie
acetylon pharmaceuticals
adverum biotechnologies
albert bourla
alzheimer's disease
ambys medicines
amgen
amicus therapeutics
arvinas
batten disease
bayer
biogen
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
cancer diagnostics
cancer immunotherapy
casimir trials
celenex
cell therapy
christine mcsherry
chuck schumer
clinial trials
constellation pharmaceuticals
What
future
2
×
today
acquisitions
aiming
albert
ambys
big
biggest
bio
biotech
bourla
ceo
company
control
crispr
deadly
deal
debuted
diseases
drug
formed
imports
launch
liver
make
maker
maps
measured
medicines
new
patients
pfizer
pfizer’s
revenue
roundup
startup
takeda
treatments
unusual
variety
Language
unknown
Current search:
future
×
startups
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
